001     303366
005     20250810021951.0
024 7 _ |a 10.1016/j.celrep.2025.116093
|2 doi
024 7 _ |a pmid:40753571
|2 pmid
024 7 _ |a 2211-1247
|2 ISSN
024 7 _ |a 2639-1856
|2 ISSN
024 7 _ |a altmetric:179937243
|2 altmetric
037 _ _ |a DKFZ-2025-01616
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Shimba, Akihiro
|b 0
245 _ _ |a Stress-induced glucocorticoids enhance acute inflammation by promoting the differentiation of Th17 cells.
260 _ _ |a Maryland Heights, MO
|c 2025
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1754316176_1839
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Stress can trigger acute inflammation by increasing the pro-inflammatory cytokine interleukin (IL)-17 for injury and infection, while inducing the production of the immunosuppressive hormone glucocorticoids (GCs). However, the mechanism through which stress-induced GCs enhance acute inflammation by directly regulating the development of IL-17-producing helper T (Th17) cells remains unclear. Here, we demonstrate that GCs promote Th17 cell differentiation and survival in both mice and humans. Stress-induced GCs augment the expansion of Th17 cells expressing low levels of TCF1, a negative regulator of IL-17 expression. In addition, GCs promote Th17 cell differentiation by enhancing glycolysis. Stress-induced GCs also increase IL-17 production and neutrophil recruitment in the intestine upon bacterial antigen stimulation. Moreover, the expansion of Th17 cells mediated by stress-induced GCs exacerbates acute colitis by promoting IL-17 production and neutrophil recruitment. Thus, stress promotes acute inflammation by enhancing the differentiation of Th17 cells through GCs, which may contribute to self-defense against infections.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a CP: Immunology
|2 Other
650 _ 7 |a IL-17
|2 Other
650 _ 7 |a Th17
|2 Other
650 _ 7 |a colitis
|2 Other
650 _ 7 |a glucocorticoid
|2 Other
650 _ 7 |a neutrophil
|2 Other
650 _ 7 |a stress
|2 Other
700 1 _ |a Cui, Guangwei
|b 1
700 1 _ |a Abe, Shinya
|b 2
700 1 _ |a Hirota, Keiji
|b 3
700 1 _ |a Miyauchi, Eiji
|b 4
700 1 _ |a Takami, Daichi
|b 5
700 1 _ |a Tani-Ichi, Shizue
|b 6
700 1 _ |a Kato, Ryoma
|b 7
700 1 _ |a Tajima, Masaki
|b 8
700 1 _ |a Kanahashi, Toru
|b 9
700 1 _ |a Miyazaki, Masaki
|b 10
700 1 _ |a Rodewald, Hans-Reimer
|0 P:(DE-He78)86fa3316b7be0d661065d02b3baec3d6
|b 11
|u dkfz
700 1 _ |a Yoshitomi, Hiroyuki
|b 12
700 1 _ |a Ueno, Hideki
|b 13
700 1 _ |a Ohno, Hiroshi
|b 14
700 1 _ |a Ikuta, Koichi
|b 15
773 _ _ |a 10.1016/j.celrep.2025.116093
|g Vol. 44, no. 8, p. 116093 -
|0 PERI:(DE-600)2649101-1
|n 8
|p 116093
|t Cell reports
|v 44
|y 2025
|x 2211-1247
909 C O |o oai:inrepo02.dkfz.de:303366
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)86fa3316b7be0d661065d02b3baec3d6
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:49:39Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-16
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-16
920 1 _ |0 I:(DE-He78)D110-20160331
|k D110
|l Zelluläre Immunologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D110-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21